SUVAXYN M.HYO VACCINE

Land: Australien

Sprache: Englisch

Quelle: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Wirkstoff:

MYCOPLASMA HYOPNEUMONIDE BACTERIN; THIOMERSAL

Verfügbar ab:

VIRBAC (AUSTRALIA) PTY LTD

INN (Internationale Bezeichnung):

vaccine - Mycoplasma hyopneum.

Darreichungsform:

MISC. VACCINES OR ANTI SERA

Zusammensetzung:

MYCOPLASMA HYOPNEUMONIDE BACTERIN VACCINE-GENERAL Active 0.0 P; THIOMERSAL MERCURY Other 0.1 mg/ml

Einheiten im Paket:

100mL; 250mL

Klasse:

VM - Veterinary Medicine

Therapiegruppe:

PIGS | BOAR | GILT | PIGLET | SOW | SWINE

Therapiebereich:

IMMUNOTHERAPY

Anwendungsgebiete:

MYCOPLASMA HYOPNEUMONIAE | REDUCTION OF LUNG LESIONS | RESPIRATORY DISEASE | SWINE ENZOOTIC PNEUMONIA

Produktbesonderheiten:

Poison schedule: 0; Withholding period: ; Host/pest details: PIGS: [MYCOPLASMA HYOPNEUMONIAE]; For the vaccination of the healthy pigs against clinical signs caused by mycoplasma hyopneumoniae by reducing of lung lesions caused by this disease organism. Aid in the reduction of mycoplasma induced respiratory disease and growth suppression.Do not vaccinate sick animals

Berechtigungsstatus:

Stopped

Berechtigungsdatum:

2018-06-30

Gebrauchsinformation

Virbac (Australia) Pty Limited
Page
1
of
2
Product Name:
Suvaxyn M.Hyo Vaccine
APVMA Number:
50420/60539
Version Date:
27 Sep2013
Pack sizes:
100
ml
(SO
doses)
250
ml
(125 Doses)
TEMPLATE
FOR
RELEVANT
LABEL
PARTICULARS
(RLPs)
(Veterinary
Products)
Select appropriate:
IJ
New Product (include all applicable RLPs)
OR
./
Variation
(highlight
instructions
that
are
being
varied).
Approval
no.
of
label
being
varied:
................
.
Signal
heading:
FOR ANIMAL TREATMENT ONLY.
Product
name:
SUVAXYN
M.
Hyo VACCINE
Active constituentls:
A
liquid
adjuvanted
bacterin
consisting
of
inactivated
Mycoplasma
hyopneumoniae
(RP
2'1.0).
Contains thiomersal
0.1
mg
/mL as a preservative.
Statement
of
claims:
For the vaccination of healthy pigs against clinical signs caused by
Mycoplasma hyopneumoniae
by the reduction of lung lesions caused by this
disease organism.
Aids in the reduction of mycoplasma induced respiratory
disease and growth suppression.
Net
contents:
100 mL(50 doses)/250 mL(125 doses)
Directions for Use
DIRECTIONS
FOR
USE:
Heading:
Restraints:
N/A
Contraindications:
Do not vaccinate sick animals
Precautions:
Allergic reactions in pigs although rare, may occur.
Side
effects:
N/A
Dosage
&
Shake well before use.
Use entire contents within 24 hours
administration:
Dose: 2
mL
intramuscularly using aseptic technique.
Sucking
pigs:
Inject 2 mL at 7 to
10
days
of
age or prior
to
weaning. Repeat
with second dose 2 to 3 weeks after first vaccination.
Introduced
growers
and breeders: Inject 2 mL at time of arrival and repeat
vaccination 2 to 3 weeks later.
General
directions:
Caution: avoid carcass damage
+
1.
Sterilise all injection apparatus by boiling before use. Avoid use of
strong
disinfectants
on
apparatus.
2.
Maintain cleanliness at all times.
RLP
3.
Keep needles sharp and clean.
·-,IJProved
4.
Use needles of appropriate gauge and length.
5.
As
far
as
possible avoid injection of animals during wet weather or under
•
VIRBAC (AUSTRALIA)
PTY
LIMITED
Page
2
of
2
PRODUCT
NAME:
SUVAXYN
M.HYO
VACCINE
APVMA
Number:
50420/60539

Fachinformation

VIRBAC (AUSTRALIA) PTY. LTD.
MATERIAL SAFETY DATA SHEET
Product Name:
Suvaxyn
®
M.Hyo Vaccine
PAGE: 1 OF 5
DATE OF ISSUE
1 FEBRUARY 2010
EMERGENCY: VIRBAC: 02 9772 9772 OR 1800 242 100 (BUSINESS HOURS ONLY)
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
COMPANY:
VIRBAC (AUSTRALIA) PTY. LTD
ABN 77 003 268 871
ADDRESS
361 Horsley Rd, Milperra, NSW 2214, Australia
Locked Bag 6000, Milperra Business Centre, NSW 1891, Australia
TELEPHONE:
[phone] or 1800 242 100
FAX:
[phone]
EMERGENCY PHONE
As above during business hours; answering machine after hours
SUBSTANCE:
Water suspension of _Mycoplasma hyopneumoniae_.
TRADE NAME:
SUVAXYN
® M.HYO VACCINE
APVMA CODE:
50420
PRODUCT USE:
Vaccination of healthy pigs against clinical signs caused by
_Mycoplasma _
_hyopneumoniae_.
CREATION DATE:
FEBRUARY, 2010
REVISION DATE:
DECEMBER, 2010
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of ASCC.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Red coloured aqueous suspension .
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
POTENTIAL HEALTH EFFECTS
NOTE: DIFFERENT HAZARD ASSESSMENT CRITERIA OF ASCC AND TGA MAY RESULT
IN SEEMING INCONSISTENCIES BETWEEN
MSDS AND LABEL. EFFECTS DESCRIBED IN THIS MSDS RELATE TO SHORT TERM
EMERGENCY SITUATIONS, SUCH AS ACCIDENTS
AND SPILLS WITH THE POTENTIAL FOR GROSS OVEREXPOSURE, AND TO LONG TERM
INDUSTRIAL AND MANUFACTURING EXPOSURE.
SEE PRODUCT LABEL FOR ASSESSMENT OF HEALTH EFFECTS OF EXPOSURE DURING
NORMAL ON-FARM